'It all depends on why it's red': qualitative interviews exploring patient and professional views of a traffic light system for in vitro fertilisation add-ons

被引:1
作者
Lensen, Sarah [1 ]
Armstrong, Sarah [2 ]
Vaughan, Emily [3 ]
Caughey, Lucy [1 ]
Peate, Michelle [1 ]
Farquhar, Cynthia [4 ,5 ]
Pacey, Allan [2 ]
Balen, Adam [6 ]
Wainwright, Elaine [7 ,8 ]
机构
[1] Univ Melbourne, Royal Womens Hosp, Dept Obstet & Gynaecol, Parkville, Vic, Australia
[2] Univ Sheffield, Med Sch, Dept Oncol & Metab, Beech Hill Rd, Sheffield, England
[3] Univ Bristol, Acad Womens Hlth Unit, North Bristol NHS Trust, Bristol, England
[4] Acad Womens Hlth Unit, North Bristol NHS Trust, Bristol, England
[5] M&HS Bldg 507,28 Pk Ave, Auckland, New Zealand
[6] Leeds Teaching Hosp NHS Trust, Great George St, Leeds, England
[7] Univ Aberdeen, Sch Med Med Sci & Nutr, Epidemiol Grp, Aberdeen, Scotland
[8] Bath Spa Univ, Univ Bath Honorary Res Fellow, Dept Hlth, Bath, England
来源
REPRODUCTION AND FERTILITY | 2023年 / 4卷 / 02期
基金
澳大利亚国家健康与医学研究理事会;
关键词
IVF add-ons; risk communication; traffic light; evidence;
D O I
10.1530/RAF-22-0136
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In vitro fertilisation (IVF) add-ons are techniques, medicines, or procedures used in addition to standard IVF with the aim of improving the chance of success. The United Kingdom's IVF regulator, the Human Fertilisation Embryology Authority (HFEA) developed a traffic light system to categorise add-ons as either green, amber, or red, based on results of randomised controlled trials. We undertook qualitative interviews to explore understanding and views of the HFEA traffic light system among IVF clinicians, embryologists, and IVF patients across Australia and the United Kingdom (n = 73). Overall, participants were supportive of the intention of the traffic light system; however, many limitations were raised. It was widely recognised that a simple traffic light system necessarily omits information which may be important to understanding the evidence. In particular, the red category was used in scenarios that patients viewed as having different implications for their decision-making, including 'no evidence' and 'evidesssnce of harm'. Patients were surprised at the absence of any green add-ons and questioned the value of a traffic light system in this context. Many participants considered the website a helpful starting point, but desired more detail, including the contributing studies, results specific to patient demographics (e.g. <35 years and >35 years), and inclusion of more options (e.g. acupuncture). Overall, participants believed the website to be reliable and trustworthy, particularly due to the Government affiliation, and despite some concerns regarding transparency and an overly cautious regulator. The limitations of the traffic light system could be considered in any future updates to the HFEA website and others developing similar decision support tools. were identified. People generally thought the system was too simple and didn't give enough information, it had limited detail about the number and types of studies included, and some important add-ons were missing, such as acupuncture.
引用
收藏
页数:12
相关论文
共 20 条
  • [1] Add-ons in the laboratory: hopeful, but not always helpful
    Armstrong, Sarah
    Atkinson, Monique
    MacKenzie, Jeanette
    Pacey, Allan
    Farquhar, Cynthia
    [J]. FERTILITY AND STERILITY, 2019, 112 (06) : 994 - 999
  • [2] VALUE study: a protocol for a qualitative semi-structured interview study of IVF add-ons use by patients, clinicians and embryologists in the UK and Australia
    Armstrong, Sarah C.
    Lensen, Sarah
    Vaughan, Emily
    Wainwright, Elaine
    Peate, Michelle
    Balen, Adam H.
    Farquhar, Cynthia M.
    Pacey, Allan
    [J]. BMJ OPEN, 2021, 11 (05):
  • [3] Patient-centred infertility care: a qualitative study to listen to the patient's voice
    Dancet, E. A. F.
    Van Empel, I. W. H.
    Rober, P.
    Nelen, W. L. D. M.
    Kremer, J. A. M.
    D'Hooghe, T. M.
    [J]. HUMAN REPRODUCTION, 2011, 26 (04) : 827 - 833
  • [4] Galiano V, 2020, HUM REPROD, V35
  • [5] Accounting for complexity in healthcare innovation debates: Professional views on the use of new IVF treatments
    Geampana, Alina
    Perrotta, Manuela
    [J]. HEALTH, 2023, 27 (06): : 907 - 923
  • [6] Human Fertilisation and Embryology Authority, 2018, Pilot National Fertility Patient Survey
  • [7] Passion, pressure and pragmatism: how fertility clinic medical directors view IVF add-ons
    Iacoponi, Olivia
    van de Wiel, Lucy
    Wilkinson, Jack
    Harper, Joyce C.
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2022, 45 (01) : 169 - 179
  • [8] Clinical adjuncts in in vitro fertilization: a growing list
    Kamath, Mohan S.
    Mascarenhas, Mariano
    Franik, Sebastian
    Liu, Emily
    Sunkara, Sesh Kamal
    [J]. FERTILITY AND STERILITY, 2019, 112 (06) : 978 - 986
  • [9] How common is add-on use and how do patients decide whether to use them? A national survey of IVF patients
    Lensen, S.
    Hammarberg, K.
    Polyakov, A.
    Wilkinson, J.
    Whyte, S.
    Peate, M.
    Hickey, M.
    [J]. HUMAN REPRODUCTION, 2021, 36 (07) : 1854 - 1861
  • [10] IVF add-ons in Australia and New Zealand: A systematic assessment of IVF clinic websites
    Lensen, Sarah
    Chen, Sheng
    Goodman, Lucy
    Rombauts, Luk
    Farquhar, Cindy
    Hammarberg, Karin
    [J]. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2021, 61 (03) : 430 - 438